The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


SKP SKYEPHARMA PLC ORD 100P

SKYEPHARMA  Currency  GBX  Premium Equity Commercial Companies


Income Statement  (£ m) 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09
Continuing Operations
Revenue  62.60 49.90 55.20 58.10 55.90
Operating Profit/(Loss)  13.60 17.10 9.80 14.50 13.70
Net Interest  14.10 11.80 0.40 12.30 13.30
Profit Before Tax  -1.00 -10.40 -1.00 6.50 -0.90
Profit After Tax  0.80 -10.60 -1.60 6.30 -1.40
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  0.80 -10.60 -1.60 6.30 -1.40
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  0.80 -10.60 -1.60 6.30 -1.40
 
Continuing EPS
Earnings per Share - Basic  1.80p -36.00p -6.70p 26.30p -6.00p
Earnings per Share - Diluted  1.70p -36.00p -6.70p 15.30p -6.00p
Earnings per Share - Adjusted  1.80p 1.10p 1.90p 29.60p 0.00p
Continuing and Discontinued EPS
Earnings per Share - Basic  1.80p -14.90p -6.70p 26.30p -6.00p
Earnings per Share - Diluted  1.70p -14.90p -6.70p 15.30p -6.00p
Earnings per Share - Adjusted  1.80p 22.20p 1.90p 29.60p 0.00p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09
Assets
Non-Current Assets
Property, Plant & Equipment  28.50 31.90 29.80 29.50 29.60
Intangible Assets  5.30 5.10 5.80 8.40 9.10
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 4.20 0.10 0.20
  33.80 37.00 39.80 38.00 38.90
Current Assets
Inventories  8.80 5.80 0.80 1.30 1.30
Trade & Other Receivables  15.50 13.30 10.50 11.50 16.50
Cash at Bank & in Hand  16.50 16.40 15.20 29.00 27.00
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 4.20 0.00
  40.80 35.50 26.50 46.00 44.80
 
Total Assets  74.60 72.50 66.30 84.00 83.70
 
Liabilities
Current Liabilities
Borrowings  -9.80 -10.10 -19.60 -27.30 -13.40
Other Current Liabilities  -23.70 -24.20 -14.80 -17.70 -13.20
  -33.50 -34.30 -34.40 -45.00 -26.60
 
Net Current Assets  7.30 1.20 -7.90 1.00 18.20
 
Non-Current Liabilities
Borrowings  -90.90 -87.00 -94.60 -100.00 -120.70
Provisions  -4.20 -5.30 -5.10 0.00 0.00
Other Non-Current Liabilities  -10.60 -11.90 -13.90 -18.90 -16.00
  -105.70 -104.20 -113.60 -118.90 -136.70
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -139.20 -138.50 -148.00 -163.90 -163.30
 
Net Assets  -64.60 -66.00 -81.70 -79.90 -79.60
 
Capital & Reserves
Share Capital  120.70 120.70 98.50 98.50 98.50
Share Premium Account  361.70 361.70 390.20 390.20 390.20
Other Reserves  -16.20 -16.40 -16.80 -16.40 -10.20
Retained Earnings  -530.80 -532.00 -553.60 -552.20 -558.10
Shareholders Funds  -64.60 -66.00 -81.70 -79.90 -79.60
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  -64.60 -66.00 -81.70 -79.90 -79.60

Ratios - based on IFRS 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09
Continuing Operations
PE Ratio - Adjusted  62.64 65.00 18.82 1.06 n/a
PEG - Adjusted  0.98 -1.54 -0.20 0.00 n/a
Earnings per Share Growth - Adjusted  63.64% -42.11% -93.58% 2959900.00% n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  135.79p 169.15p 230.00p 242.08p 238.89p
Pre-Tax Profit per Share  -2.17p -35.25p -4.17p 27.08p -3.85p
Operating Margin  20.45% 2.40% -1.45% 31.33% 21.11%
Return on Capital Employed  37.43% 4.47% -1.89% 42.63% 25.25%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  -151.53p -154.14p -365.45p -368.79p -370.46p
Net Gearing  -130.34% -122.27% -121.18% -123.03% -134.55%

Data is provided by Morningstar


SKYEPHARMA share - fundamentals

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds